Director, Oncology Medical Engagement Excellence

At Bristol Myers Squibb, our employees often ask, “Who are you working for?”—a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits.

This is work that transforms the lives of patients, and the careers of those who do it.

Summary

At BMS, the Medical Engagement Excellence (MedEngageX) team is positioned within the Medical Excellence (Med Ex) organization. MedEngageX plays a critical role in ensuring that healthcare professionals are educated on the appropriate use of our medicines and have the information they need to improve outcomes for patients. We develop strategies, tools, and guidance to empower our medical teams (Home Office, Market Field Medical [FM], and Medical Engagement Leads [MELs]) around the globe to ensure that they are aware, informed, engaged, and equipped with the knowledge and skills to perform their roles effectively and compliantly.

Directors within MedEngageX serve as strategic partners across the medical organization, connecting global medical strategy with coordinated execution in the field to drive consistent, high-impact customer engagement.

Key Accountabilities

• Report to the Senior Director, International Markets Medical Engagement Excellence within the Medical Engagement Excellence (MedEngageX) team.
• Serve as an active partner to global medical strategic planning through participation in Pumitamig and Thoracic Cancers Asset Indication Medical Strategy (AIMS) teams and its Working Groups, launch teams, and other cross-functional teams—informing medical strategy development, driving and leveraging medical insights, and representing the voice of Field Medical (FM) teams across global markets, including alignment of engagement priorities and coordination of customer-facing activities through Medical Engagement Leads (MELs).
• Facilitate the pull though of medical strategies/initiatives relevant to the (field) medical teams in support of the medical objectives for Pumitamig and Thoracic Cancers, to ensure aligned and coordinated customer engagement across field roles.
• Partner with WW Medical, WW Medical Learning teams to ensure effective communication and the pull through of the scientific narrative(s) and Patient Outcome Imperatives (POIs) for Pumitamig and Thoracic Cancers.
• Partner with WW Medical to ensure strategic alignment and focus of topics and data relevant for scientific exchange, and for the development of corresponding Medical Communication Topics (MCTs) and insights.
• Foster collective efforts across matrix and market medical teams to optimize medical insight quality, analysis, communications and reporting; accountable for high functioning global Fast Insight Review (FIRe) teams, Insights to Action process and evolving this process with the implementation of AI enabled tools.
• Build strong partnerships with Global Drug Development, Health Economics and Outcomes Research (HEOR), and Medical Evidence Generation teams to ensure field medical teams are equipped with the direction, training, communication, and resources needed to support priority BMS-sponsored studies.
• Identify and drive opportunities to optimize, innovate, and standardize deliverables and ways of working across TAs, assets, and indications—ensuring visibility and maximizing the value of MedEngageX and field medical teams as customer-facing partners in the organization.

Strategy

• Accountable for FM therapeutic area strategies, guidance, franchise resources, WW FM study support…